Your browser doesn't support javascript.
loading
A randomized pharmacokinetic-pharmacodynamic evaluation of the potential biosimilar interferon beta-1a product, CinnoVex®.
Scheinin, Mika; Lovró, Zsófia; Maadik, Inger-Helen; Suopanki-Lalowski, Jaana; Seyedagha, Seyed Hossein; Azhdarzadeh, Morteza.
Affiliation
  • Scheinin M; Medical Department, CRST Oy, Itäinen Pitkäkatu, Turku, Finland.
  • Lovró Z; Medical Department, CRST Oy, Itäinen Pitkäkatu, Turku, Finland.
  • Maadik IH; Statistical Department, StatFinn Estonia & EPID Research (IQVIA) Narva Mnt 9, Tartu, Estonia.
  • Suopanki-Lalowski J; Clinical Operations/Projects Unit, Crown CRO Oy, Espoo, Finland.
  • Seyedagha SH; CinnaGen Medical Biotechnology Research Center, Alborz University of Medical Sciences, Karaj, Iran.
  • Azhdarzadeh M; CinnaGen Medical Biotechnology Research Center, Alborz University of Medical Sciences, Karaj, Iran.
Expert Opin Biol Ther ; 22(2): 169-178, 2022 Feb.
Article in En | MEDLINE | ID: mdl-33678097
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biosimilar Pharmaceuticals Type of study: Clinical_trials / Prognostic_studies Limits: Humans Language: En Journal: Expert Opin Biol Ther Journal subject: BIOLOGIA / TERAPEUTICA Year: 2022 Document type: Article Affiliation country: Finlandia Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biosimilar Pharmaceuticals Type of study: Clinical_trials / Prognostic_studies Limits: Humans Language: En Journal: Expert Opin Biol Ther Journal subject: BIOLOGIA / TERAPEUTICA Year: 2022 Document type: Article Affiliation country: Finlandia Country of publication: Reino Unido